article_metadata: Jitka Smetanova Tomas Milota Michal Rataj Jana Hurnakova Hana Zelena Rudolf Horvath
article_metadata: 10.3389/fimmu.2022.1017232
article_metadata: Front Immunol
article_metadata: 2022 Nov 9;13:1017232.
article_metadata: covid-19 sars-cov-2 fibrodysplasia ossificans progressive immunogenicity safety vaccination
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36439163/
article_metadata: COVID-19 Vaccines / administration & dosage COVID-19 / prevention & control Myositis Ossificans Vaccines
article_metadata: COVID-19 Vaccines / administration & dosage COVID-19 / prevention & control Myositis Ossificans Vaccines Research Support, Non-U.S. Gov't BNT162 Vaccine Humans Immunity, Cellular SARS-CoV-2 BNT162 Vaccine COVID-19 Vaccines Vaccines
article_metadata: PMC9682080
article_metadata: 36439163
article_metadata: SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients
article_metadata: 2022